Dear Contractor

The Department of Health NI issued correspondence here dated 15 January 2026, extending the expiry dates of SSP060 and SSP061 for Creon® 10,000 and 25,000 gastro-resistant capsules respectively.

  • SSP060 will now expire on Friday 30 January 2026.
  • SSP061 will now expire on Friday 17 April 2026.

BACKGROUND

  • SSPs made under the Human Medicines Regulations 2012 are an additional tool to manage and mitigate medicines shortages.
  • SSPs enable community pharmacists to supply specified medicines in accordance with a protocol rather than a prescription, without needing to seek authorisation from the prescriber – saving time for patients, pharmacists and prescribers.
  • Pharmacists should refer to the latest versions of the existing SSPs which are now available on the Business Services Organisation dedicated page on its website HERE.
  • Operational guidance on the implementation of SSPs in Northern Ireland can be found on the BSO website HERE.

ACTION

Contractors should:

  • Review the letter here dated 15 January 2026, and ensure that their dispensary teams are aware of the extension of the expiry dates of SSP060 and SSP061 to Friday 30 January 2026 and Friday 17 April 2026 respectively;
  • Note the specific details relating to these SSPs including guidance relating to the decision pathways for SSPs; notification of GPs; the need for patient/carer agreement, and action to take when this is not given; professional judgement; and actions regarding unclear quantities.

Contractors are reminded of information issued by BSO ‘Serious Shortage Protocols: Submission Information for Contractors’ which can be accessed here.

Contractors should contact their local SPPG office in the first instance should further information be required.  CPNI colleagues are also available for assistance.

Kind regards

Mike

SENT ON BEHALF OF
PROF MIKE MAWHINNEY
Head of Regulatory Affairs

Reminder: Complaints Return Due by Monday 26th January 2026
Dear Contractor
SPPG issued correspondence on 20 January 2026 which is marked as an URGENT REMINDER for community pharmacies to ensure they have submitted their mandatory Complaints Returns via the online form by Monday 26th January 2026.

SUMMARY

The correspondence reminds community pharmacies:

  • To submit the monthly complaints return by Monday 26 January 2026.
  • The January return covers all closed complaints for December 2025.
  • A NIL return is submitted if there are no closed complaints. 
  • Returns are submitted using the online form.
  • Closed complaints in January should be submitted via the February return.
  • Further information on the Model Complaints Process is available on the BSO website here.
  • SPPG has developed a guidance pack including:

ACTION

  • Contractors should note the information in the SPPG correspondence and share with relevant members of their pharmacy teams.
  • Community pharmacies should ensure they submit their complaints return by Monday 26th January 2026.
  • If you are experiencing any issues submitting your return, please contact Complaints.SPPG@hscni.net or speak to your local SPPG office.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Colleague
SPPG issued correspondence dated 11 December 2025 in relation to the Community Pharmacy Assurance Framework (CPAF) declaration for 2025/2026. The deadline for community pharmacies to submit their CPAF declaration was 16 January 2026, which has now passed.  However SPPG has indicated that returns will be accepted and would encourage pharmacies who have not yet submitted a return to do so as soon as possible.

For those who have already submitted no further action is required at this time.  For those who are yet to submit, you can do so via the online form. Note: It may be helpful to save a copy or screenshot of your submission for your pharmacy records.

SUMMARY

The SPPG letter states:

  • The Community Pharmacy Assurance Framework (CPAF) for 2025/26 consists of an annual declaration completed by each community pharmacy contractor, and a short visit undertaken by SPPG staff for a selected number of pharmacies each year.
  • The purpose of the framework is to monitor compliance with Terms of Service, service specifications, related professional standards and best practice guidance.
  • The annual CPAF declaration must be completed via the online form by no later than 16 January 2026.
  • A payment of £1400 will be made to each community pharmacy, upon return of the completed declaration, for compliance with the CPAF process in 2025/26.
  • Those community pharmacies selected for a CPAF visit will be contacted directly with further information. A visit protocol is available here.
  • Queries relating to CPAF can be directed to your SPPG Pharmacy Adviser, via your local office.

ACTION

Contractors should:

  • Read and note the SPPG correspondence and share with relevant members of the pharmacy team.
  • If not already completed, ensure your pharmacy’s CPAF declaration is submitted via the online form ASAP.
  • Contact the relevant SPPG local office for further support if required.

If you have any further queries please do not hesitate to contact a member of the CPNI team.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Reminder: NICPLD IP Training Course – Application Window Open
Dear Contractor
The application window for the next NICPLD IP training course (commencing August/September 2026) is now open.  The closing date for applications is Tuesday 3 March 2026.

Full details are available on the NICPLD website here.

SUMMARY

  • 50 IP training places are available for community pharmacists.
  • Applicants will be responsible for finding their own DPP.
  • A payment of £1,500 is available for each DPP supporting a community pharmacist.

ACTION

Contractors may wish to note the information on the NICPLD website and share with relevant members of the pharmacy team including:

  • Community pharmacists who are interested in undertaking IP training.
  • Community pharmacist IPs who might consider acting as a DPP.

Queries regarding the IP training course can be sent to nicpld-prescribing@qub.ac.uk.  Alternatively, if you wish to speak to a member of the CPNI team you may contact Ennis.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
This update contains important information for community pharmacy teams.

CPNI ALERTS

DOH(NI) ALERTS

BSO ALERTS

Pharmacy team(s) can keep updated via CPNI’s Contractor Calendar and Contractor Emails.

Or report medicine shortages, pricing and staffing issues via CPNI’s Medicine Pricing/Supply Reporter and Situation Reporter.

Please bring this to the attention of your pharmacy team(s).

Kind regards

SENT ON BEHALF OF
Gerard Greene
Chief Executive
Dear Colleague
The first update of concessionary prices were granted today for January 2026:
DrugPack SizeConcessionary Price
Amoxicillin 250mg/5ml oral suspension100£1.44
Aspirin 75mg dispersible tablets28£2.19
Aspirin 75mg dispersible tablets100£7.82
Betamethasone 500microgram soluble tablets sugar free100£47.89
Carbocisteine 375mg capsules120£5.00
Citalopram 20mg tablets28£0.92
Clarithromycin 250mg/5ml oral suspension70£26.48
Co-careldopa 25mg/100mg tablets100£7.51
Co-codamol 8mg/500mg capsules100£26.78
Co-codamol 8mg/500mg capsules32£8.57
Fenofibrate micronised 267mg capsules28£17.30
Fexofenadine 180mg tablets30£3.75
Hydroxychloroquine 200mg tablets60£2.05
Ibandronic acid 150mg tablets1£18.40
Irbesartan 150mg tablets28£2.01
Lactulose 3.1-3.7g/5ml oral solution500£6.62
Lansoprazole 30mg orodispersible tablets28£3.20
Methenamine hippurate 1g tablets60£19.57
Midazolam 10mg/2ml solution for injection ampoules10£4.68
Mometasone 0.1% cream100£11.06
Mometasone 0.1% cream30£3.50
Naftidrofuryl 100mg capsules84£10.50
Nizatidine 150mg capsules30£65.35
Oxycodone 5mg/5ml oral solution sugar free250£6.42
Promethazine hydrochloride 25mg tablets56£1.85
Propranolol 160mg modified-release capsules28£5.90
Propranolol 40mg tablets28£1.15
Propranolol 80mg modified-release capsules28£24.40
Sodium bicarbonate 500mg capsules56£5.60
Tibolone 2.5mg tablets28£4.50
Tolterodine 2mg tablets56£12.88
Tolterodine 4mg modified-release capsules28£25.70
Valsartan 80mg capsules28£7.00
Zolmitriptan 2.5mg orodispersible tablets sugar free6£4.38

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Please continue to notify CPNI of any pricing issues you are experiencing via our Medicine Pricing/Supply Reporter.

Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive